source_name
A549, MCF7 and K562 cells
cell type
A549 human lung adenocarcinoma, MCF7 breast adenocarcinoma and K562 chronic myelogenous leukemia cells
treatment
Cells were treated with increasing doses of a library of 188 small molecule inhibitors or dmso vehicle control.